These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9807699)

  • 1. The development of monoclonal antibodies for the therapy of cancer.
    Farah RA; Clinchy B; Herrera L; Vitetta ES
    Crit Rev Eukaryot Gene Expr; 1998; 8(3-4):321-56. PubMed ID: 9807699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant antibodies: from the laboratory to the clinic.
    Albrecht H; DeNardo SJ
    Cancer Biother Radiopharm; 2006 Aug; 21(4):285-304. PubMed ID: 16999595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials of antibody therapy.
    Glennie MJ; Johnson PW
    Immunol Today; 2000 Aug; 21(8):403-10. PubMed ID: 10916144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant antibodies for cancer therapy.
    Deonarain MP
    Expert Opin Biol Ther; 2008 Aug; 8(8):1123-41. PubMed ID: 18613764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays.
    Golay J; Introna M
    Arch Biochem Biophys; 2012 Oct; 526(2):146-53. PubMed ID: 22387378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An overview of antibody-based cancer therapy].
    Miao QF; Shao RG; Zhen YS
    Yao Xue Xue Bao; 2012 Oct; 47(10):1261-8. PubMed ID: 23289136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An overview of antibody therapy against cancer].
    Taniguchi H; Imai K
    Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
    Ricart AD; Tolcher AW
    Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
    Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
    J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies in single-chain format against tumour-associated antigens: present and future applications.
    Accardi L; Di Bonito P
    Curr Med Chem; 2010; 17(17):1730-55. PubMed ID: 20345346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybridoma technology: the preferred method for monoclonal antibody generation for
    Zaroff S; Tan G
    Biotechniques; 2019 Sep; 67(3):90-92. PubMed ID: 31347924
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.
    Derby L; Czuczman MS
    Future Oncol; 2011 Aug; 7(8):963-79. PubMed ID: 21823892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.
    Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U
    Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody therapy for malignant glioma.
    Chen KS; Mitchell DA
    Adv Exp Med Biol; 2012; 746():121-41. PubMed ID: 22639164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer.
    Chester KA; Mayer A; Bhatia J; Robson L; Spencer DI; Cooke SP; Flynn AA; Sharma SK; Boxer G; Pedley RB; Begent RH
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S8-12. PubMed ID: 10950140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic antibodies and related products: choosing the right structure for success].
    Beck A; Wagner-Rousset E; Wurch T; Corvaia N
    Med Sci (Paris); 2009 Dec; 25(12):1024-32. PubMed ID: 20035674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies and gene therapy: teaching old 'magic bullets' new tricks.
    Sanz L; Blanco B; Alvarez-Vallina L
    Trends Immunol; 2004 Feb; 25(2):85-91. PubMed ID: 15102367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-related drugs for cancer therapy.
    Li GN; Wang SP; Xue X; Qu XJ; Liu HP
    Drug Discov Ther; 2013 Oct; 7(5):178-84. PubMed ID: 24270381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.